GoldenGolden
Advanced Search
micropharma

micropharma

A microbiome company offering probiotics for heart diseases, diabetes, obesity and other diseases

Micropharma Limited discovers and develops bacteria as biotherapeutics for metabolic diseases. The Company uses its proprietary discovery and development platform ProSelect to screen and select bacteria capable of expressing phenotypic traits that can effectively target metabolic pathways recognized as having therapeutic potential.

Timeline

January 24, 2013
micropharma raises a $851,242 seed round.

Funding rounds

People

Name
Role
LinkedIn

Andrei Dan

Employee

Robert Semmens

Investor

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.